Related Experiment Video
Updated: Mar 2, 2026

The Intra-Aortic Balloon Pump
Published on: February 5, 2021
Current role of ischemia-modified albumin in routine clinical practice
Alberto Dominguez-Rodriguez1, Pedro Abreu-Gonzalez
1Hospital Universitario de Canarias, Department of Cardiology, Tenerife, Spain. adrvdg@hotmail.com
Background:
Ischemia-modified albumin has been proposed as a useful rule-out marker for the diagnosis of acute coronary syndrome in the emergency department.
Objective:
To perform a review of ischemia-modified albumin use in the clinical practice.
Methods:
We performed a comprehensive literature search by using electronic bibliographic databases.
Conclusion:
Although the main limitation of ischemia-modified albumin at present is its low specificity, it may be a useful test to rule out acute coronary syndrome from low to moderate pre-test probability conditions with negative cardiac troponins and a negative ECG.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Drug Distribution: Plasma Protein Binding
Anticoagulant Drugs: Low-Molecular-Weight Heparins